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Background: Histone acetyltransferases (HATs) incorporated in large multiprotein complexes are involved in a wide
variety of cellular processes, including transcription regulation.
Results: Subunits of HAT complexes enhance the enzymatic activity of their catalytic subunits.
Conclusion: The activity, but not the specificity of HAT complexes, is stimulated by the corresponding subunits.
Significance:We gained important insights into histone acetylation function and specificity of HAT complexes.
Histone acetyl transferases (HATs) play a crucial role in
eukaryotes by regulating chromatin architecture and locus spe-
cific transcription. GCN5 (KAT2A) is a member of the GNAT
(Gcn5-related N-acetyltransferase) family of HATs. In metazo-
ans this enzyme is found in two functionally distinct coactivator
complexes, SAGA (Spt Ada Gcn5 acetyltransferase) and ATAC
(Ada Two A-containing). These two multiprotein complexes
comprise complex-specific and shared subunits, which are orga-
nized in functionalmodules. TheHATmodule of ATAC is com-
posed of GCN5, ADA2a, ADA3, and SGF29, whereas in the
SAGA HAT module ADA2b is present instead of ADA2a. To
better understand how the activity of human (h) hGCN5 is reg-
ulated in the two related, but different, HAT complexes we car-
ried out in vitro HAT assays. We compared the activity of
hGCN5 alone with its activity when it was part of purified
recombinant hATAC or hSAGA HAT modules or endogenous
hATAC or hSAGA complexes using histone tail peptides and
full-length histones as substrates. We demonstrated that the
subunit environment of the HAT complexes into which GCN5
incorporates determines the enhancement ofGCN5activity.On
histone peptides we show that all the tested GCN5-containing
complexes acetylate mainly histone H3K14. Our results suggest
a stronger influence of ADA2b as compared with ADA2a on the
activity of GCN5. However, the lysine acetylation specificity of
GCN5 on histone tails or full-length histones was not changed
when incorporated in the HAT modules of ATAC or SAGA
complexes. Our results thus demonstrate that the catalytic
activity of GCN5 is stimulated by subunits of the ADA2a- or
ADA2b-containing HAT modules and is further increased by
incorporation of the distinct HAT modules in the ATAC or
SAGA holo-complexes.
Post-translational modifications of histones regulate tran-
scription activation or repression. Nucleosomes composed of a
(H3-H4)2 tetramer flanked by two H2A-H2B dimers wrapped
by 147 base pairs of DNA play a key role in chromatin compac-
tion (1). To loosen chromatin structure and activate gene
expression, transcription activators first bind to their cognate
DNA binding sites and subsequently recruit multisubunit
coactivator complexes. Around enhancers and promoter ele-
ments, coactivator complexes can then either reorganize the
nucleosomes by using ATP-dependent chromatin remodeling
factors or modify histones covalently. Chromatin-modifying
coactivator complexes dynamically deposit and remove post-
translational modifications on histones, thus creating or eras-
ing docking surfaces for proteins that recognize histone modi-
fications (2).
One of the first histone modifications discovered was acety-
lation of lysine residues. This modification is thought to acti-
vate gene expression by loosening the chromatin structure but
also by creating docking surfaces for other proteins and protein
complexes (2–5). GCN5 (also called KAT2A) was the first his-
tone acetyltransferase (HAT)5 or lysine (K) acetyltransferase
(KAT) - enzyme to be identified and was classified to be part
of the GNAT (Gcn5-related N-acetyltransferase) family of
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enzymes. Its activity as an acetyltransferase on histone sub-
strates was first described in Tetrahymena (6). Later it was
shown that this enzyme is homologous to the yeast Gcn5 pro-
tein, already known to be required for transcriptional activation
(7–10). Gcn5 is evolutionary highly conserved from yeast to
human (5, 11). Initial in vitro studies using microsequencing of
labeled yeast histoneH3 orH4 peptides and recombinant Gcn5
indicated that the enzyme displays a non-random specificity,
mainly acetylating histone H3 at Lys-14 and to some extent H4
at Lys-8 position (12). A recent quantitative high throughput
mass spectrometry-based assay, when using free recombinant
histone H3 alone as substrate, demonstrated recombinant
Gcn5-mediated acetylation at six lysineswith the following effi-
ciency: Lys-14 Lys-9 Lys-23 Lys-18 Lys-27 Lys-36)
(13).
Yeast (y) Gcn5 is part of two coactivator complexes, SAGA
(Spt-Ada-Gcn5 acetyltransferase) and ADA (14). Mammalian
GCN5was also described to be part of two large HAT complex,
called SAGA (15–17) orATAC (Ref. 18 and references therein).
The mammalian SAGA complexes all contain 18–19 evolu-
tionary well conserved subunits (18). Interestingly, it was dem-
onstrated that the subunits of SAGA complexes are organized
in functionally distinct modules, including the HAT, the deu-
biquitination, and the structural and the activator interaction
modules (18, 19). Originally, it was shown in yeast that yGcn5
interacts with yAda2 and yAda3 to form an Ada/Gcn5 module,
which is important for acetylation of histones H3 andH4 (9, 20,
21). Also in human cells, hGCN5 interacts with hADA2b and
hADA3 (22). More recently, Lee et al. (19) discovered that
ySgf29 is also part of this HAT module. Thus, yGcn5 and
hGCN5 are subunits of the HAT modules of the respective
SAGA complexes, together with yAda2/hADA2b, yAda3/
hADA3, and ySgf29/hSGF29.
A study combining in vitro acid-urea gel and quantitative
mass spectrometry approach to measure the activity of yeast
Gcn5 incorporated in the partial HAT module of the ySAGA
and Ada complexes containing Gcn5-Ada2-Ada3 showed that
Gcn5 acetylated free histone H3 with the following efficiency:
H3K14 H3K23 H3K9 H3K18 H3K27 H3K36 (23).
Purified yeast and human SAGA complexes were shown in
vitro to acetylate H3 mainly at position Lys-14, but also Lys-9,
Lys-18, and Lys-23 to some extent when using different pre-
acetylated H3 tail peptides (24, 25).
Metazoan GCN5 was identified also as a subunit of a second
coactivator HAT complex in Drosophila (26) and mammals,
named ATAC (Ada two A-containing) (26, 27). Interestingly,
the yAda2 protein has two paralogues in metazoans: ADA2a
andADA2b (28, 29). AlthoughADA2b is part of theHATmod-
ule of the SAGA complex, ADA2a was shown to be a subunit of
the HAT module of the ATAC complex together with GCN5,
ADA3, and SGF29 (18, 28, 29).
In addition to the diversity of GCN5-containing HAT com-
plexes in metazoans, a second level of complexity exists in ver-
tebrate organisms. In vertebrates, another HAT protein called
PCAF (p300/CREB-binding protein (CBP)-associated factor, or
KAT2B) is present that is 70% identical to GCN5 (30). Similarly
to GCN5, PCAF can acetylate histones H3 and H4 (31). In
mammalian cells no free GCN5 or PCAF is found. Both pro-
teins are always integrated into either theATACor SAGAcom-
plexes. The presence of GCN5 or PCAF in SAGA or ATAC is
mutually exclusive (27, 32).
Although eukaryotic SAGA complexes preferentially acety-
late histoneH3K9 andH3K14 lysine residues in vivo (24, 25, 33,
34), specificities of themetazoanATAC complexes are less well
understood (27, 35, 36). After knock down of ATAC subunits a
decrease of acetylated H4K5 and acetylated H4K12, or H4K16
was observed in Drosophila (37–39). In contrast, analyses of
changes in histone tail acetylation patterns upon knock-out or
knockdownof specific ATAC subunits inmammalian cells sug-
gested that ATAC preferentially acetylates histone H3 rather
than H4 (27, 35, 36). A recent mass spectrometry-based strat-
egy to precisely and accurately quantify histonemarkmodifica-
tions inDrosophilaKCcells after RNAi ablation ofGCN5 (pres-
ent in ATAC and SAGA) demonstrated H3 acetylation marks
decrease in the following order: H3K9K14 H3K9 
H3K14  H3K27  H3K36 (34). Note that in this study no
changes in H4 acetylation were reported after GCN5 knock-
down, suggesting potentially redundant action of several other
HATs on H4. Interestingly, this compensatory activity in vivo
did not occur on H3. Furthermore, knock-out of yeast Gcn5 or
knockdown of the ATAC and SAGA HAT module activity in
mammalian cells resulted in a significant genome-wide reduc-
tion ofH3K9acmark at all active gene promoters (33). In agree-
ment, deletion of GCN5 and PCAF in mammalian cells specif-
ically and dramatically reduced acetylation on histone H3K9
(40).
In this study we set out to determine how the subunits of
ATAC or SAGA HAT complexes regulate the activity of the
GCN5 enzyme. To this end we compared the activities of the
recombinant GCN5 enzyme in isolation, the GCN5-containing
HAT modules of ATAC and SAGA, and the corresponding
endogenous holo-complexes. In vitro acetylation assays per-
formed on histone tail peptides, H3/H4 tetramers, and histone
octamers as substrates show that GCN5 alone is less active
when compared with its activity in the HAT modules or to the
endogenous ATAC or SAGA complexes. Thus, the protein
partners of GCN5 enhance its activity.
Experimental Procedures
DNA Constructs and Recombinant Protein Production—The
His6-FLAG-hGCN5-expressing construct was described in
Demény et al. (41). Recombinant ATAC and SAGAHATmod-
ules were produced using the MultiBac system (42). Coding
sequences for human GCN5, human ADA2a/b, mouse ADA3,
andhumanSGF29were insertedby sequence and ligation-inde-
pendent cloning into the vectors pFL, pIDC, pIDK, and pIDS,
respectively (43). The 5 region of the GCN5 gene was engi-
neered to code for a decahistidine tag followed by a tobacco
etch virus protease cleavage site. Vectors were fused by Cre
recombination and integrated into the EMBacY baculovirus
genome via Tn7 transposition (44). Recombinant baculoviruses
were generated as described (44) and used for protein complex
production in Sf21 insect cell culture. Infected insect cells were
harvested 72 h post cell arrest by centrifugation and stored at
80 °C until further use.
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Immunoprecipitation and Western Blot Analysis—Prepara-
tion of HeLa cell nuclear extract was described in Demény et al.
(41). Sf9 cell lysates were made as described in Leurent et al.
(45). Proteins from insect Sf9 cell lysates (from four 75-cm2
Falcon flasks) or from 4 mg of HeLa cell nuclear extracts were
immunoprecipitated with 100 l of protein G-Sepharose (GE
Healthcare) and 20 g of the different antibodies (as indi-
cated in Fig. 1). His6-FLAG-hGCN5 was purified using anti-
FLAGM2-agarose beads (Sigma). Antibody-proteinG-Sephar-
ose- or M2-agarose-bound protein complexes were washed 3
times with immunoprecipitation (IP) buffer (25 mM Tris-HCl,
pH 7.9, 10% (v/v) glycerol, 0.1% Nonidet P-40, 0.5 mM DTT, 5
mMMgCl2) containing 0.5 M KCl and twice with IP buffer con-
taining 100 mM KCl. After washing, proteins were eluted by a
1000	 excess of the corresponding epitope peptide (for the
anti-GCN5 5GC2A6 monoclonal antibody (mAb), MAEP-
SQAPTPAPAAQPRPLC; for anti-ADA3 pAb 2678, LEG-
KTGHGPGPGRPKSKN; for anti-ADA2a 2AD2A1 mAb,
MDRLGSFSNDPSDKPPC; for anti-TAF10 23TA1H8 mAb,
MSCSGSGADPEAAPASAASAC) (see also Fig. 1). Proteins
were then visualized by staining the gels with Coomassie Bril-
liant Blue or silver stain or transferred to nitrocellulose mem-
branes and probed with the indicated primary antibodies.
Chemiluminescence detection was performed according to
manufacturer’s instructions (Amersham Biosciences). All anti-
bodies raised against human ATAC or SAGA subunits used in
this study were described previously (27). The anti-GCN5
mouse mAb 2GC was raised against the CKCNGWKNPK-
PPTAP epitope (amino acids 118–132 of hGCN5), and the
anti-GCN5 mAb 4GC was raised against the IWESGFT-
MPPSEGTQLVPC epitope (amino acids 374–391 of hGCN5).
Antibodies used for detection of histone modifications on
Western blot were: H3K14 (46), H3K9Ac (#06-942; Millipore),
and H4K5Ac (ab51997; Abcam).
Peptide Acetylation Assay—Histone tail peptides (1 g; cor-
responding to the N-terminal tail of histone H3 or H4, as indi-
cated in the figures) was added to the purified protein samples
together with 1 l of H3-labeled acetyl-coenzyme A (0.05 Ci
per reaction) or 14C-labeled acetyl-coenzyme A (0.04 Ci per
reaction) in buffer R (50 mM Tris-HCl, pH 8, 20 mM KCl, 5 mM
DTT, 4mMEDTA) and incubated at 30 °C for 1 h. Sampleswere
deposited on Whatman P81 nitrocellulose filters, washed 3
times for 10 min in ice-cold 50 mM NaHCO3, pH 9, buffer, and
dried. Filters were then dropped into 5 ml of ReadySafe liquid
scintillation mixture (Beckman Coulter), and radioactivity was
quantified by an LS6000SC Beckman counter.
Histone Acetylation Assay—Histones were purified from
HeLa cells as described (47). Recombinant histone octamer
purification was described in Tropberger et al. (48). Per reac-
tion, 300 ng of histones were incubatedwith 14C-labeled acetyl-
coA (0.04 Ci per reaction) and 20–100 ng of the indicated
GCN5-containing complexes in HAT buffer (50 mM Tris-HCl,
pH 7.9, 10% glycerol, 0,1mM EDTA, 50mMKCl, 20mM sodium
butyrate, 1 mM DTT, and protease inhibitors). The reactions
were incubated for 1 h at 30 °C, stopped by adding Laemmli
buffer with 100 mM DTT, and boiled for 10 min. Proteins were
then loaded on a 13% SDS-PAGE and analyzed by Coomassie
Brilliant Blue staining. The gel was then incubated for 20min in
Amplify reagent (GE Healthcare; NAMP100) and dried. A
blank phosphorimaging screen (Fuji) was placed on the gel, and
the radioactive signal was analyzed and quantified with a
Typhoon 8600 scanner.
Mass Spectrometric Identification of Histone Acetylation—
For large scale histone acetylation assays, 1 g of recombinant
human histone octamers (reconstituted with H3.2 variant)
were incubated with 100 ng of GCN5-containing complexes
and 200Mcold acetyl-coA. Reactionswere incubated for 1 h at
37 °C in HAT buffer and frozen at80°. Protein mixtures were
then separated in two equal parts and TCA-precipitated over-
night at 4 °C. Samples were centrifuged at 14,000 rpm for 30
min at 4 °C, and pellets were washed twice with 500 l of cold
acetone and urea-denatured with 8 M urea in 0.1 mM Tris-HCl,
reduced with 5 mM tris(2-carboxyethyl)phosphine for 30 min,
and then alkylated with 10mM iodoacetamide for 30min in the
dark. Both reduction and alkylation were performed at room
temperature and under agitation (850 rpm). One-half of the
samples was double-digested with endoproteinase Lys-C
(Wako) at a ratio 1/100 (enzyme/proteins) in 8 M urea for 6 h
followed by an overnight-modified trypsin digestion (Promega)
at a ratio of 1/100 (enzyme/proteins) in 2 M urea at 37 °C. The
second half was digested with ArgC (Promega) at a ratio of
1/100 (enzyme/protein) in 4 M urea for 12 h at 37 °C. Peptide
mixtures were then desalted on C18 spin-column and dried on
a speed vacuum before LC-MS/MS analysis.
LC-MS/MS Analysis—Samples were analyzed using an Ulti-
mate 3000 nano-RSLC (Thermo Scientific, San Jose, California)
coupled in line with an linear trapQuadrupole (LTQ)-Orbitrap
ELITE mass spectrometer via a nano-electrospray ionization
source (Thermo Scientific). Peptide mixtures were loaded on a
C18 Acclaim PepMap100 trap column (75 m inner diame-
ter	 2 cm, 3 m, 100 Å; Thermo Fisher Scientific) for 3.5 min
at 5 l/min with 2% acetonitrile (ACN), 0.1% formic acid in
H2O and then separated on a C18 Accucore nano-column (75
m inner diameter 	 50 cm, 2.6 m, 150 Å; Thermo Fisher
Scientific) with a 120-min linear gradient from5% to 50%buffer
B (A: 0.1% FA in H2O; B: 80% ACN, 0.08% FA in H2O) followed
with 10 min at 99% B. The total duration was set to 150 min at
a flow rate of 200 nl/min. The temperature was kept constant at
40 °C. Peptides were analyzed by Top 10-CID-HCD (collision
induced dissociation and high energy collision dissociation)
data-dependent mass spectrometry.
Data Analysis—Proteins were identified by database search-
ing using SequestHT (Thermo Fisher Scientific) with Proteome
Discoverer 1.4 software (Thermo Fisher Scientific), a human
Swissprot database (release 2015_04, 20,169 entries). Precursor
mass tolerance was set at 7 ppm, and fragment mass tolerances
were set at 0.5Da and 20 ppm for collision-induced dissociation
and high energy collision dissociation fragmentation, respec-
tively. Trypsin orArgCwas set as enzyme, and up to twomissed
cleavages were allowed.Oxidation (M) and acetyl (Lys) were set
as variable modifications, and carbamidomethylation (C) was
set as fixed modification. Peptides were filtered with a score
versus charge state (1.5 z1, 2.5 z2, 3 z3, and 3.2 z 4) and rank
1. Identified acetylated peptides resulting from the two diges-
tions were combined.
ATAC and SAGA Subunits Stimulate GCN5 Activity
NOVEMBER 27, 2015•VOLUME 290•NUMBER 48 JOURNAL OF BIOLOGICAL CHEMISTRY 28999
 at U
niversity of Bristol Library Services on M
arch 16, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Results
Purification of GCN5- and GCN5-containing Complexes—
To test whether the incorporation of human GCN5 in either
the ATAC or SAGAHATmodules or, alternatively, in the cor-
responding endogenous human ATAC and SAGA holocom-
plexes influence its activity and specificity, we set out to purify
GCN5 and the respective complexes. Recombinant FLAG-
tagged GCN5 was purified from baculovirus-infected Sf21
insect cells by anti-FLAG IP followed by FLAG peptide elution
(Fig. 1A).
Subunits corresponding to either the HAT module of
hATAC (GCN5, ADA2a, ADA3, and SGF29) or those of the
HAT modules of hSAGA (GCN5, ADA2b, ADA3, and SGF29)
were produced in insect cells using the MultiBac expression
system (44, 49). Recombinant proteins were purified from
extracts of MultiBac-infected Sf21 insect cells by double
immunoprecipitation against hGCN5 and ADA3 (Fig. 1B).
SDS-PAGE analysis of the purified fractions showed co-im-
munoprecipitation of the four subunits in apparently stoi-
chiometric amounts, indicating that the recombinant pro-
teins assemble in stable ATAC HAT module or SAGA HAT
module (Fig. 1C).
Endogenous ATAC and SAGA complexes were purified by
tandem IPs from human HeLa cell nuclear extracts (Fig. 1, D
andE). To purify endogenousATACcomplexes, the first IPwas
performed by using an antibody against hADA2a, an ATAC-
specific subunit, and eluted with the corresponding peptide
(Fig. 1D). To obtain only GCN5 (KAT2A)-containing ATAC
complexes (and to eliminate PCAF (KAT2B)-containing
ATAC complexes), we carried out a second affinity purification
using an anti-GCN5 antibody, which purified the endogenous
GCN5-containing ATAC complex (Fig. 1,D, F, andG). Despite
the fact that in human cells both GCN5- and PCAF-containing
ATAC complexes exist, hereafter we will call the GCN5-con-
taining ATAC complexes “ATAC,” for simplicity. To purify
endogenous SAGA, the first IP was performed by using an anti-
body against hTAF10 (a subunit of SAGA and TFIID). To
exclusively purify SAGA complexes that contain GCN5, the
second IP was performed using an antibody raised against
hGCN5, and endogenous GCN5-containing SAGA complexes
were elutedwith the corresponding peptide (Fig. 1, E, F, andG).
Despite the fact that in human cells both GCN5- and PCAF-
containing SAGA complexes exist, hereafter we will call the
GCN5-containing SAGA complexes “SAGA” for simplicity.
The protein composition of the endogenous complexes was
tested by Western blot (WB) assays using antibodies against
either shared (ADA3 and SGF29) or specific subunits (ZZZ3
and ADA2b) (Fig. 1F) and by silver staining (Fig. 1G). To verify
whether the immunopurified endogenous ATAC and SAGA
complexes would contain contaminating HATs other than
GCN5 or PCAF, the anti-ADA2a and the anti-TAF10 IPs (see
Fig. 1, D and E) were subjected to mass spectrometry analyses.
We did not detect any otherHATs thanGCN5 andPCAF in the
analyzed IPs (supplemental Table 1).
GCN5 Needs to Be Incorporated in Its Corresponding HAT
Modules or Endogenous HAT Complexes to Exert Its Full Activ-
ity on Histone Tail Peptides—To compare the specific HAT
activity of GCN5 among the recombinant baculovirus over
expressed samples and endogenous protein complex prepara-
tions, they were normalized for GCN5. First the recombinant
GCN5 and ATAC and SAGA HAT module preparations were
normalized either by Coomassie Blue staining orWB assays by
using two different anti-GCN5mouse mAbs (Fig. 2A). Next we
verified whether the two different anti-GCN5 mAbs would
detect the same way the recombinant and the endogenous
human (h) GCN5s in the different preparations (Fig. 2B). As we
did not observe any differences in their detection specificity, we
used the 2GC mAb to normalize GCN5 among the recombi-
nant baculovirus-overexpressed samples and endogenous pro-
tein complex preparations (Fig. 2C). Note that as the recombi-
nant hGCN5 is FLAG- and His-tagged, it migrates slightly
slower (Fig. 2A, lanes 1, 2, and 4) than the endogenous non-
tagged hGCN5 in ATAC and SAGA complexes (Fig. 2, B andC,
lanes 3 and 5).
Next, the enzymatic activities of recombinant GCN5 alone,
incorporated into either the recombinant ATAC HAT or
SAGA HATmodules, or the two endogenous ATAC or SAGA
holocomplexes were measured by peptide acetylation assays
using an N-terminal histone H3 peptide ranging from amino
acids 5 to 20 (Fig. 2D). Interestingly, in this assay the same
amount of GCN5 was 3–8 times more active when incorpo-
rated in either of the HATmodules or 12–14 timesmore active
when part of the endogenous ATAC or SAGA complexes (Fig.
2, D and F). As ATAC has been described to acetylate also
histone H4 (27, 35, 36), we tested the activity of GCN5 alone
and the different purified complexes on a histone H4 tail pep-
tide encompassing amino acids 1–19 (Fig. 2E). We observed
that the same amount of GCN5 was only slightly more active
(1.5-fold) on the H4 tail peptide when incorporated in the
recombinant HAT modules but 5 times more active in the
endogenous ATAC or SAGA holo-complexes (Fig. 2, E and F).
Generally, the proteins and complexes were 10 times more
active on the H3 tail peptide than on the H4 tail peptide (Fig. 2,
D and E). Interestingly, we found that the acetylation activity of
GCN5 is generally stimulated to a higher extent in the SAGA-
type HAT module than in ATAC-type HAT module (Fig. 2, D,
E, and F), suggesting a differential stimulatory role of ADA2a
andADA2b. Because the activity of GCN5 is further stimulated
upon incorporation of the HAT modules into the correspond-
ing endogenous HAT complexes, we conclude that distinct
subunit environments in the HAT modules or in the endoge-
nous complexes play a stimulatory role in the regulation of the
activity of GCN5. Note, however, that post-translational mod-
ifications of GCN5 in the endogenous complexes may also par-
ticipate in this stimulatory activity. Alternatively, the purifica-
tion of rGCN5 alone, without its natural protein environment,
may partially inhibit its activity.
ADA2b Has a Stronger Stimulatory Activity on GCN5 Than
ADA2a—As the ATAC and SAGA HAT modules share the
three subunits GCN5, ADA3, and SGF29, we postulate that the
significant differences in acetylation activity of the ATACHAT
and the SAGA HAT modules on H3 peptides originate from
sequence differences in the ADA2a and ADA2b subunits,
which are 45% similar. To test this hypothesis, we produced and
ATAC and SAGA Subunits Stimulate GCN5 Activity
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FIGURE 1. Purification of GCN5, recombinant HAT modules, and endogenous ATAC and SAGA complexes. A, purification of recombinant GCN5. SDS-
PAGE analysis of the GCN5 purification procedure showed input and unbound samples (lanes 1 and 2, respectively), the peptide elutions (lanes 4 and 5), and
GCN5-bound antibody beads before elution (lane 6). Proteins were visualized by Coomassie Brilliant Blue (CBB) stain. The antibody heavy chains (Ig HC) and
light chains (Ig LC) are indicated.MW, molecular massmarker (170, 125, 95, 75, 55, 36, and 24 kDa). B, purification scheme of the recombinant ATAC and SAGA
HAT modules (rHAT ATAC and rHAT SAGA). SN, supernatant. Elution, peptide elution with a 1000	 excess of peptide against which the indicated antibodies
were raised. C, purification of recombinant HAT modules of ATAC and SAGA. SDS-PAGE analysis of the purified complexes following the procedure depicted
in B. Proteins were visualized by Coomassie Brilliant Blue stain. Note that the ATAC HAT module contains ADA2a, whereas the SAGA HAT module contains
ADA2b. MW, molecular mass marker (as in panel A), and protein identities are indicated on the left and right of the gel, respectively. D and E, schematic
representationof thepurificationof endogenousGCN5-containingATACandSAGAcomplexes fromHeLa cell nuclear extracts. SN, supernatant containing the
unbound proteins. Elution, peptide elutionwith a 1000	 excess of peptide against which the indicated antibodies were raised.GCN5-ATAC, GCN5-containing
ATACcomplex;GCN5-SAGA, GCN5-containingSAGAcomplex.F,Westernblot analysesof endogenousATAC (lane1) andSAGA (lane2) complexes following the
purification procedures depicted in D and E, respectively. Recombinant GCN5 (lane 3) was also analyzed as the control. Note that the recombinant hGCN5 is
FLAG tagged, and thus it migrates slightly slower than the endogenous hGCN5 in ATAC and SAGA. Primary antibodies are indicated on the right. GCN5, ADA3,
and SGF29 are common subunits of ATAC and SAGA, whereas ZZZ3 and ADA2b are ATAC- and SAGA-specific subunits, respectively. The GCN5 content of the
endogenous complexes was normalized to the amount of recombinant GCN5. G, the subunits of endogenous ATAC (lane 2) and SAGA (lane 3) complexes
purified as depicted inD and E, respectively, were visualized by silver nitrate staining. The subunits of the respective complexes are indicated. Molecular mass
markers (MW; lane 1) are indicated in kDa. The antibody heavy chains (Ig HC) and light chains (Ig LC) are indicated.
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purified recombinant heterotrimeric (GCN5/ADA3/ADA2a or
ADA2b) and heterotetrameric (GCN5/ADA3/SGF29/ADA2a or
ADA2b) HAT modules. Because GCN5 does not form stable
dimeric complexes with either ADA2a or ADA2b alone, we did
not test the influence of these single subunits on acetylation activ-
ity of GCN5 (22, 50).6 Subunit compositions of the multimeric
recombinant complexes were verified by Western blot (Fig. 3A).
When we tested the tri- and tetrameric complexes in our peptide
acetylation assays on H3 tail peptides, we found that the ADA2a-
containingHAT complexes were about two times less active than
the ADA2b-containing HAT complexes (Fig. 3B). These results
show that ADA2b has a stronger stimulatory effect on the HAT
activity of GCN5 than ADA2a. Interestingly, the incorporation of
SGF29 in the respective HAT modules, either ATAC type or
SAGA type, did not further stimulate the activity of GCN5.
6 A. Riss, E. Scheer, M. Joint, S. Trowitzsch, I. Berger, and L. Tora, unpublished
observations.
FIGURE 2. Acetylation activity of the GCN5 enzyme depended on its protein environment. A, normalization of recombinant GCN5 and GCN5-containing
HAT complexes. Amounts of purified recombinant ATAC HAT and SAGA HAT modules were normalized to recombinant GCN5 and analyzed by either
Coomassie Blue (CB) staining or by WB with two different anti-hGCN5 mouse mAbs 2GC and 4GC. B, purified recombinant GCN5, ATAC HAT, and SAGA HAT
modules and endogenous ATAC and SAGA complexes were tested by WB with two different anti-hGCN5 mouse mAbs 2GC and 4GC. C, amounts of purified
recombinant GCN5, ATAC HAT, and SAGA HAT modules and endogenous ATAC and SAGA complexes were normalized by WB with the anti-hGCN5 mouse
mAbs 2GC. Note that in panels B and C the recombinant hGCN5 is FLAG- and His-tagged alone, or incorporated in the HATmodules (lanes 1, 2, and 4). Thus, it
migrates slightly higher than the endogenous non-tagged hGCN5 (lanes 3 and 5).D, acetylation of an H3 tail peptide revealed by a filter-binding assay. H3 tail
peptide covering amino acids 5–20 was incubated with radioactive acetyl-coenzyme A and the indicated protein or protein complex preparation. Reactions
were carried out in quadruplicate in the presence (H3 amino acids 5–20) or absence of the H3 tail peptide, and acetylation was measured in cpm. Error bars
indicate S.D. E, acetylation assay as inD but with an H4 tail peptide encompassing residues 1–19. F, -fold activation of GCN5 activity of the HATmodules or the
endogenous ATAC and SAGA complexes compared with the activity of recombinant GCN5 on the H3 and H4 tail peptides used in D and E. Activation was
calculated from three biological replicates. Error bars represent S.D.
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Subunits of ATAC and SAGA Complexes Enhance Both the
Substrate Binding and the Turnover Rate of GCN5-Substrate
Complexes—To obtain more insights into the specific role of
the GCN5-associated proteins, we set out to determine the
kinetics of acetylation by GCN5 alone or incorporated into
endogenous HAT complexes. To this end we measured acety-
lation rates by filter binding assays at increasing concentrations
of H3 peptide (amino acids 1–20) at constant acetyl-CoA con-
centrations (Fig. 4A). The obtained data were fitted to the
Michaelis-Menten equation. Compared with GCN5 alone, the
endogenous ATAC and SAGA complexes decrease the Km of
GCN5 alone from 410 M to 180 M (for ATAC) and 105
M (in the case of SAGA) (Fig. 4,A andB). These results suggest
that subunits of ATAC and SAGA complexes enhance H3 pep-
tide binding. Next the turnover rate of GCN5 alone-, ATAC-,
and SAGA-substrate complex was determined by calculating
kcat. Our measurements indicate that ATAC and SAGA sub-
units also increase the turnover rate of GCN5 alone fromkcat
1.33 s1 to3.5 s1 (forATAC) or 3.1 s1 (for SAGA) (Fig. 4B).
The kcat/Km calculations show that the incorporation of GCN5
in endogenous HAT complexes increases the catalytic effi-
ciency of GCN5 by 6 (in ATAC) to 10-fold (in SAGA) (Fig.
4B). Thus our results demonstrate that the distinct subunits of
ATAC and SAGA complexes can enhance both the substrate
binding and the turnover rate of GCN5-substrate complexes.
GCN5 HAT Activity on Histone H3/H4 Tetramers Is Stimu-
lated by Interactions with ATAC and SAGA Subunits—To
assess the influence of the globular domains of histones on the
acetylation activity of GCN5 andGCN5-containing complexes,
we compared the activities of normalized amounts of GCN5-
containing complexes on H3/H4 tetramers and H2A/H2B
dimers purified from HeLa cells (Fig. 5A). In good agreement
with previous observations (Ref. 22 and references therein),
neither GCN5 nor the GCN5-containing complexes acetylated
purified human H2A/H2B dimers (Fig. 5B). Interestingly, we
hardly detected any acetylation activity of GCN5when we used
H3/H4 tetramers in theHATassay (Fig. 5C, lane 2). In contrast,
acetylation on histone H3 was detected when using either the
HAT modules of ATAC or SAGA (Fig. 5C, lanes 3 and 5,
respectively) or the two endogenous HAT complexes (Fig. 5C,
lanes 4 and 6, respectively). Quantification of the HAT assays
showed a gradually increasing activity of GCN5 on histone H3
from the recombinant HAT modules to the endogenous com-
plexes (Fig. 5D). Under the conditions used, the recombinant
HAT complexes preferentially acetylated histone H3, whereas
the endogenous ATAC and SAGA complexes showed also
weak activity on H4 (Fig. 5D). Importantly, these results on
full-length histones reflect the acetylation assays with histone
tail peptides and corroborate that the interaction partners of
GCN5 within the distinct complexes play an important role in
regulating GCN5 enzymatic activity.
FIGURE3.AcetylationactivityofGCN5wasdifferentially regulatedby the
subunits ADA2a or ADA2bwithin recombinant HATmodules. A, Western
blot analysis of purified recombinant GCN5 and heterotrimeric and heterote-
trameric recombinant HAT modules of ATAC and SAGA. Primary antibodies
used to identify subunits are indicated on the right. Amounts of GCN5 within
the HATmoduleswere normalized to recombinant GCN5. B, acetylation of an
H3 tail peptide by recombinant GCN5 and heterotrimeric and heterotetra-
meric HAT modules of ATAC and SAGA. Experimental conditions were as in
Fig. 2B. Subunit compositions of the HAT modules tested are indicated.
FIGURE 4. Subunits of ATAC and SAGA complexes enhanced both the
substrate binding and the turnover rate of GCN5-substrate complexes.
A, kinetic measurements comparing the activity of GCN5 alone with endog-
enous purified ATAC and SAGA complexes on different concentration of H3
tail peptide (from amino acid 1–20) using [14C]acetyl CoA in a filter binding
assay. Peptidebound radioactivitywasquantified in twobiological replicates.
The activities of the different GCN5-containing preparations are represented
in cpm. B, summary of kinetic parameter calculations.
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Next we performed HAT assays using recombinant histone
octamers as substrates (Fig. 5,A, lane 3, and E). Using the same
enzyme preparations on either recombinant octamers or
tetramers purified from HeLa cells, we observed very similar
enhancement of GCN5 activity by its incorporation in the dif-
ferent complexes (compare Fig. 5, C, D, and E). These results
further demonstrate that the proteins interactingwithGCN5 in
the distinct complexes stimulate the GCN5 catalytic activity to
a similar extent on purified endogenous H3/H4 tetramers and
recombinant histone octamers. As histone octamers may have
a tendency to dissociate into dimers or tetramers under certain
in vitro reaction conditions, the octamers used here and later in
our study may also be considered simply as H2A/H2B dimers
and H3/H4 tetramers, which may not be physiological sub-
strates of these complexes in vivo.
The Lysine Acetylation Specificity of GCN5 on Histone Tails
or Full-length Histones Is Not Changed When Incorporated in
the HAT Modules of ATAC or SAGA Complexes—Next we
asked whether GCN5 alone or incorporated in the endogenous
HAT complexes has different acetylation specificity. To this
end, we carried out HAT assays using distinct histone H3 pep-
tides that covered theH3 tail from amino acids 1 to 40 (Fig. 6A).
In this assay the only two peptides thatwere acetylated by either
GCN5 or the endogenous ATAC and SAGA complexes were
those that contained the H3 tail sequences encompassing
amino acids 5–20 (Fig. 6A).
To identify acetylation sites with single residue resolution,
we used histone H3 tail peptides encompassing amino acids
5–20, where the three potential acetylation sites Lys-9, Lys-14,
and Lys-18 were individually mutated to arginine (Fig. 6B). We
again compared specificity of GCN5 alone with the specificity
of GCN5 in endogenous complexes. Interestingly, only the
H3K14R mutation had a drastic inhibitory effect on the HAT
activity of bothGCN5 and the endogenous complexes, suggest-
FIGURE 5. The acetylation activity of GCN5 on recombinant histone assemblies gradually increased with subunit complexity of the HATmodules. A,
purification of human H2A/H2B dimers, H3/H4 tetramers, and histone octamers. SDS-PAGE analysis of H2A/H2B dimers and H3/H4 tetramers purified from
human HeLa cells and recombinant histone octamers produced in Escherichia coli. Proteins were visualized by Coomassie brilliant blue (CBB) stain. Protein
identities are indicated. B, acetylation tests on purified HeLa H2A/H2B dimers with recombinant GCN5, the HAT modules of ATAC and SAGA, and the
endogenous ATAC and SAGA complexes. H2A/H2B dimers were incubated with radioactive acetyl-coenzyme A and normalized amounts of GCN5- and
GCN5-containing complexes. Histones were resolved by 15% SDS-PAGE and dried, and radioactive signals were detected by radiography using an image
intensifier screen. C, acetylation tested were as in B but purified HeLa H3/H4 tetramers were used. D, quantification of acetylation of histones H3 and H4 by
GCN5-containing complexes. Quantified signals from two experiments are displayed in arbitrary units with signal deviations indicated as error bars. E,
acetylation tests as in B but performed on recombinant histone octamers.
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ing that H3K14 is the main acetylation site for GCN5 in isola-
tion and associated with the endogenous complexes.
To test whether pre-acetylation of H3 lysine residues could
have an influence on the GCN5-mediated acetylation of adja-
cent lysine residues, we generatedH3 tail peptides (amino acids
5–20), in which each of the three lysine residues were synthet-
ically pre-acetylated at the same time (Fig. 6C). Interestingly,
pre-acetylation of H3K14 abolished acetylation of all the other
sites in the peptide. These results corroborate that in our H3
peptide acetylation assay, the main acetylation site for GCN5 is
H3K14, independent of the subunit environment of GCN5.
Taken together, we showhere thatGCN5 specifically acetylates
lysine H3K14 in isolation and when incorporated in the endog-
enous complexes and that the activity, but not the specificity, of
the enzyme is altered when incorporated in the endogenous
complexes.
We had observed a weak histone H4 acetylation activity of
GCN5when incorporated inATAC and SAGA complexes (Fig.
FIGURE 6. In peptide tail HAT assays the specific acetylation site of GCN5 and the endogenous HAT complexes was H3K14, whereas on full-length
histones theacetylation specificitywasbroader.A, acetylation assays onH3 tail peptides. HistoneH3 tail peptides encompassingdifferent regionsof theH3
tail (as indicated) were assayed for acetylation by recombinant GCN5 and the purified endogenous ATAC and SAGA complexes as in Fig. 2B. Reactions were
carried out in quadruplicate, and acetylation was measured in cpm. B, acetylation assays as in A but using H3 (amino acids 5–20) peptides in which lysine
residues Lys-9, Lys-14, and Lys-18 were consecutively substituted with arginines. C, acetylation assays as in A but using the H3 (amino acids 5–20) peptide in
which lysine residues Lys-9, Lys-14, and Lys-18 were consecutively substituted with acetylated lysines. D, acetylation tests on recombinant histone octamers
with normalized amounts of recombinant GCN5, the HAT modules, and the endogenous complexes (as indicated). Protein preparations were assayed for
acetylation activity on recombinant octamers as in Fig. 4 but with cold acetyl-CoA. Histone octamers were resolved by SDS-PAGE and probed for acetylation
by Western blot using the indicated antibodies. Successful transfer of histones to the membrane was verified by Ponceau S stain.
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2E). Therefore, we next tested whether the specificity of GCN5
would changewhen assayed on a 19-mer histoneH4 tail peptide
in which the four potential lysine residues were individually
mutated to arginine (Fig. 6B). Neither of the Lys-to-Arg muta-
tions significantly abolished theweakHATactivity of the tested
ATAC or SAGA complexes, suggesting that there is no specific
acetylation site on these H4 peptides (Fig. 6B).
Next we analyzed the acetylation specificity of the different
GCN5-containing complexes on recombinant octamers using a
“cold” HAT assay and by revealing the acetylation sites with
specific antibodies raised either against H3K9ac, H3K14ac, or
H4K5ac (Fig. 6D). In this acetylation test all theGCN5-contain-
ing preparations acetylated H3K9 and H3K14; however, with
gradually increasing activity, as described above (Fig. 6D, see
also Fig. 5). This experiment suggests that on histone octamer
(or H2A/H2B dimers and H3/H4 tetramers), the acetylation
specificity of GCN5 is broader than on H3 tail peptides, but the
specificity of the GCN5 does not change when incorporated in
the HAT modules or in the endogenous complexes.
GCN5 Alone or Incorporated in the HATModule of ATAC or
SAGACan Acetylate Histone H3 andH4 at Very Similar Lysine
Positions in Octamers—To determine all the acetylation sites of
GCN5 alone or in the HATmodules of ATAC or SAGA and to
identify their preferred sites of acetylation on recombinant his-
tone octamers (or H2A/H2B dimers and H3/H4 tetramers), we
established a mass spectrometry-based approach in conjunc-
tion with large scale HAT assays (Fig. 7). HAT reactions were
carried out under saturating conditions with cold acetyl-CoA.
Histones were then digested by trypsin and ArgC, and the
obtained peptides were subjected to LC-MS/MS analysis using
an Orbitrap. From their mass spectra peptide-spectrum,
matches were determined containing no, one, two, or three
FIGURE 7.GCN5and theHATmodules ofATACor SAGAacetylated the same lysine residues onhistoneoctamers.A and B, acetylation reactionswere set
upwith GCN5 and the HATmodules of ATAC or SAGA using recombinant histone octamers. Acetylated lysine residues were identified on histone H3 (A) or H4
(B) by LC-MS/MS analysis using Orbitrap. The numbers of specific acetylated peptide-spectrum matches (PSM) containing the indicated different individual
lysine (K) residues or their identified combination (as indicated) on H3 or H4 are represented. Buffer, the reaction in which no enzyme was included (control).
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acetylated lysine positions. The number of peptide-spectrum
matches obtained for a given acetylated lysine residue either on
histoneH3 (Fig. 7A) orH4 (Fig. 7B) in the threeGCN5-contain-
ing fractions is represented including the negative control sam-
ple. These data show that under the used in vitro conditions on
histone octamers, GCN5 alone or incorporated in the HAT
module of ATAC or SAGA can acetylate histone H3 and H4 at
very similar lysine positions (Fig. 7, A and B). The preferred
acetylation sites ofGCN5on the recombinant histone octamers
(or H2A/H2B dimers and H3/H4 tetramers) are the following:
H3K9K14, H3K14, H3K23, H3K18K23, H3K27K36,
H3K27K36K37, and H4K5K8, H4K8, H4K8K12,
H4K79K91 (Fig. 7B). In this assay no significant acetylation
was detected on positions H3K4, H3K9 (alone), H3K18 (alone),
H3K36 (alone), H3K37 (alone), H3K56, H3K64, H3K79 (alone),
H3K115, and H3K122, and H4K5 (alone), H4K12, H4K16,
H4K20, H4K31, H4K44, H4K59 and H4K77, H4K79, and
H4K91. These data, taken together, further show that the acety-
lation specificity did not change when GCN5 acted alone or
incorporated in theHATmodules of eitherATAC, or SAGAon
recombinant histone octamers (or H2A/H2B dimers and
H3/H4 tetramers).
Discussion
Nuclear acetyltransferases are involved in a wide variety of
cellular processes, including transcription regulation, chroma-
tin structure, DNA repair, cell cycle control, and many others.
However, it remains unclear how acetyltransferase enzymes are
regulated and how such regulation controls the acetylation of
specific targets at given lysine residues. Ahuge variety of in vitro
and in vivomethods was employed to characterize the function
of GCN5, but none systematically tested its activity and speci-
ficity alone or associated with its structural modules or com-
plexes.We set out to understandGCN5 acetylation in a system-
atic way, starting from the isolated enzyme and by building up
the corresponding HAT complexes.
Our study demonstrates that the subunits of the HAT mod-
ules and the incorporation of theHATmodules in to the endog-
enous complexes enhance the enzymatic activity ofGCN5.This
is important, as in cells GCN5 is always incorporated into
endogenous complexes, such as SAGA and ADA in yeast, or
ATAC and SAGA in metazoan cells (18, 27, 51). Moreover, in
our assays using normalized GCN5 amount-containing com-
plexes we found that the ADA2b-containing SAGAHATmod-
ule stimulated theHAT activity of GCN5 better than that of the
ADA2a-containing ATAC HATmodule. It has been described
that ADA2b, but not ADA2a, increases the acetylation of
nucleosomes by GCN5 (22). Both ADA2a and ADA2b have
SANT and SWIRM domains that are found in several proteins
implicated in chromatin function. Analyses of the role of the
SANT domain in yeast Ada2p revealed that the domain was
required for full HAT activity of the associated Gcn5p (52, 53)
and suggested that the SANTdomain of yAda2p is a histone tail
binding or presentation module (52). Thus, it is possible that
the ADA2b SANT domain plays a role in the recognition of
histones and that the related ADA2a SANT domain has a
weaker histone tail binding or presentation capability. To fur-
ther dissect the roles of SANT and/or SWIRM domains in the
enhanced regulation of GCN5 and to provide insight into the
mechanism of histone acetylation by the ADA2a- or ADA2b-
containing HAT modules, chimeric ADA2a and ADA2b pro-
teins have to be created for further functional tests. Impor-
tantly, when the ATAC- or SAGA-type HAT modules are
associated with the corresponding endogenous complexes, the
HAT activity of GCN5 is further stimulated, suggesting that the
HATmodules’ interactionswith the respective other functional
modules in the ATAC or SAGA complexes would further
accommodate the HAT modules structures for a full activity.
Nevertheless, the full activities of the two endogenous com-
plexes (normalized for GCN5) are rather comparable under all
our assay conditions.
Recent structural and functional studies of the second enzy-
matic module of SAGA, the deubiquitination (DUB) module,
also demonstrated an allosteric regulation of DUB enzymes
(yUbp8 or hUSP22) through multiple interactions with other
subunits of the DUBmodule of SAGA (54–56). These observa-
tions together with the above-described regulation of GCN5
suggest a common principle for the regulation of the enzymatic
activities of ATAC and SAGA and may be even for all chroma-
tin-modifying complexes with enzymatic activities.
In contrast to the enhanced activity of GCN5 by the corre-
sponding subunits, the incorporation of GCN5 in different
complexes did not significantly change the specificity of the
different GCN5-containing enzyme preparations using H3 and
H4 tail peptides, full-length H3/H4 tetramers, or recombinant
histone octamers as substrates in our in vitro assays. Interest-
ingly, however, we observed a broadening of the lysine acetyla-
tion specificity of GCN5 and the corresponding complexes
when we used either full-length endogenous histone H3/H4
tetramers or recombinant histone octamers. In peptide tail
assays all the activities acetylated strongly and specifically
H3K14 (and 10 times less H4), whereas in the assays using
full-length histones or recombinant histone octamers the spec-
ificity broadened. On histone octamers (or H2A/H2B dimers
and H3/H4 tetramers) GCN5 and the HAT modules were able
to specifically acetylate H3 and/or H4 tail residues and/or their
well defined combinations (H3K9K14, H3K14, H3K23,
H3K18K23, H3K27K36, H3K27K36K37, and
H4K5K8, H4K8, H4K8K12, H4K79K91; Fig. 7). These
data together suggest that the main site targeted by GCN5 on
H3 tail is H3K14 and that either GCN5 or the other HATmod-
ule subunits are able to bind H3/H4 tetramers or histone
octamers, which would then target GCN5 to additional sites,
such as H3K9, H3K23, H3K27, H3K36, H4K5, and H4K8. It is
thus conceivable that histone fold recognition/binding via
SANT domains of ADA2a or ADA2b could bring the histone
tails in close proximity to the catalytic site of GCN5, therefore,
broadening the specificity due to local enrichment. In contrast,
whenusing tail peptides local enrichmentwould not be possible
and only “perfect fit” peptides would have high enough affini-
ties to be acetylated. Note, however, that H3/H4 tetramers
and/or histone octamers may not represent the physiological
targets of ATAC and SAGA in vivo. In future experiments it
would be interesting to test whether pre-methylated and/or
pre-acetylated histone octamers or nucleosomes would change
the specificity of the HAT and/or the endogenous complexes
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toward certain lysine residues. Nevertheless, in our assays the
GCN5-dependent acetylation sites are specific, as we did not
obtain significant acetylation on several lysine residues present
either on tails or globular domains of H3 or H4 (Fig. 7).
The enhanced substrate recognition and turnover of GCN5
by its associated subunits in ATAC or SAGA could play an
important role in the function of these complexes. GCN5
within the SAGA complex is recruited at specific loci on the
genome, where it will act on its specific histone substrates. The
targeting of GCN5 to the chromatin is suggested to be carried
out by several “reading domains” of SAGA and ATAC com-
plexes, such as the bromodomain of GCN5 itself binding to
acetylated chromatin marks and/or the SGF29 double Tudor
domain known to bind H3K4 trimethylation (57–59). Thus,
future structural and further enzymatic studies will be required
to better understand the acetylation function, specificity, and
targeting the GCN5-containing complexes to recombinant
nucleosomes, premodified nucleosomes, and different chroma-
tin templates in either the context of the ATAC or the SAGA
HAT complexes.
Author Contributions—A. R. designed, performed, and analyzed the
experiments and wrote the first draft of the paper. E. S. performed
experiments. L. T. designed and performed the experiments shown
in Fig. 7, andM. J. analyzed the experiments shown in Fig. 7. S. T. and
I. B. constructed and provided the MultiBac expression vectors and
participated in writing the paper. All authors reviewed the results
and approved the final version of themanuscript. L. T. conceived and
coordinated the study and wrote the paper.
Acknowledgments—We are grateful to Z. Nagy, J. Bonnet, M. Stierle,
P. Tropberger, C. Bieniossek, E. Y. D. Chua, and C. A. Davey for mate-
rials, helpful discussions, and advice. We thank D. Devys for critically
reading the manuscript and for helpful comments, the Institut de
Génétique et de Biologie Moléculaire et Cellulaire cell culture facility
for HeLa cells, I. Kolb-Cheynel for help in baculovirus overexpression,
P. Eberling for peptide synthesis, K. J. Babu for technical help, and F.
Garzoni for tissue culture work. The Institut de Génétique et de Biolo-
gie Moléculaire et Cellulaire Proteomics platform is supported by an
Association pour la Recherche sur le Cancer grant (Orbitrap).
References
1. Kornberg, R. D., and Lorch, Y. (1999) Twenty-five years of the nucleo-
some, fundamental particle of the eukaryote chromosome. Cell 98,
285–294
2. Kouzarides, T. (2007) Chromatin modifications and their function. Cell
128, 693–705
3. Hong, L., Schroth, G. P., Matthews, H. R., Yau, P., and Bradbury, E. M.
(1993) Studies of the DNA binding properties of histone H4 amino termi-
nus. Thermal denaturation studies reveal that acetylation markedly re-
duces the binding constant of the H4 “tail” to DNA. J. Biol. Chem. 268,
305–314
4. Li, R., Yang, L., Fouts, E., and Botchan, M. R. (1993) Site-specific DNA-
binding proteins important for replication and transcription have multi-
ple activities. Cold Spring Harb. Symp. Quant. Biol. 58, 403–413
5. Nagy, Z., andTora, L. (2007)DistinctGCN5/PCAF-containing complexes
function as co-activators and are involved in transcription factor and
global histone acetylation. Oncogene 26, 5341–5357
6. Brownell, J. E., and Allis, C. D. (1995) An activity gel assay detects a single,
catalytically active histone acetyltransferase subunit in Tetrahymena ma-
cronuclei. Proc. Natl. Acad. Sci. U.S.A. 92, 6364–6368
7. Penn, M. D., Galgoci, B., and Greer, H. (1983) Identification of AAS genes
and their regulatory role in general control of amino acid biosynthesis in
yeast. Proc. Natl. Acad. Sci. U.S.A. 80, 2704–2708
8. Hinnebusch, A.G., and Fink,G. R. (1983) Positive regulation in the general
amino acid control of Saccharomyces cerevisiae. Proc. Natl. Acad. Sci.
U.S.A. 80, 5374–5378
9. Marcus, G. A., Silverman, N., Berger, S. L., Horiuchi, J., and Guarente, L.
(1994) Functional similarity and physical association between GCN5 and
ADA2: putative transcriptional adaptors. EMBO J. 13, 4807–4815
10. Georgakopoulos, T., and Thireos, G. (1992) Two distinct yeast transcrip-
tional activators require the function of the GCN5 protein to promote
normal levels of transcription. EMBO J. 11, 4145–4152
11. Candau, R., Moore, P. A., Wang, L., Barlev, N., Ying, C. Y., Rosen, C. A.,
and Berger, S. L. (1996) Identification of human proteins functionally con-
served with the yeast putative adaptors ADA2 and GCN5.Mol. Cell. Biol.
16, 593–602
12. Kuo, M. H., Brownell, J. E., Sobel, R. E., Ranalli, T. A., Cook, R. G., Ed-
mondson, D. G., Roth, S. Y., and Allis, C. D. (1996) Transcription-linked
acetylation by Gcn5p of histones H3 and H4 at specific lysines. Nature
383, 269–272
13. Kuo, Y. M., and Andrews, A. J. (2013) Quantitating the specificity and
selectivity of Gcn5-mediated acetylation of histone H3. PLoS ONE 8,
e54896
14. Grant, P. A., Duggan, L., Côté, J., Roberts, S.M., Brownell, J. E., Candau, R.,
Ohba, R., Owen-Hughes, T., Allis, C. D., Winston, F., Berger, S. L., and
Workman, J. L. (1997) Yeast Gcn5 functions in two multisubunit com-
plexes to acetylate nucleosomal histones: characterization of an Ada com-
plex and the SAGA (Spt/Ada) complex. Genes Dev. 11, 1640–1650
15. Ogryzko, V. V., Kotani, T., Zhang, X., Schiltz, R. L., Howard, T., Yang, X. J.,
Howard, B. H., Qin, J., and Nakatani, Y. (1998) Histone-like TAFs within
the PCAF histone acetylase complex. Cell 94, 35–44
16. Martinez, E., Kundu, T. K., Fu, J., and Roeder, R. G. (1998) A human
SPT3-TAFII31-GCN5-L acetylase complex distinct from transcription
factor IID. J. Biol. Chem. 273, 23781–23785
17. Wieczorek, E., Brand, M., Jacq, X., and Tora, L. (1998) Function of
TAF(II)-containing complex without TBP in transcription by RNA poly-
merase II. Nature 393, 187–191
18. Spedale, G., Timmers, H. T., and Pijnappel, W.W. (2012) ATAC-king the
complexity of SAGA during evolution. Gene Dev. 26, 527–541
19. Lee, K. K., Sardiu, M. E., Swanson, S. K., Gilmore, J. M., Torok, M., Grant,
P. A., Florens, L., Workman, J. L., and Washburn, M. P. (2011) Combina-
torial depletion analysis to assemble the network architecture of the
SAGA and ADA chromatin remodeling complexes.Mol. Syst. Biol. 7, 503
20. Horiuchi, J., Silverman, N., Marcus, G. A., and Guarente, L. (1995) ADA3,
a putative transcriptional adaptor, consists of two separable domains and
interacts with ADA2 and GCN5 in a trimeric complex.Mol. Cell. Biol. 15,
1203–1209
21. Pollard, K. J., and Peterson, C. L. (1997) Role for ADA/GCN5 products in
antagonizing chromatin-mediated transcriptional repression. Mol. Cell.
Biol. 17, 6212–6222
22. Gamper, A. M., Kim, J., and Roeder, R. G. (2009) The STAGA subunit
ADA2b is an important regulator of human GCN5 catalysis. Mol. Cell.
Biol. 29, 266–280
23. Cieniewicz, A. M., Moreland, L., Ringel, A. E., Mackintosh, S. G., Raman,
A., Gilbert, T. M., Wolberger, C., Tackett, A. J., and Taverna, S. D. (2014)
The bromodomain of Gcn5 regulates site specificity of lysine acetylation
on histone H3.Mol. Cell. Proteomics 13, 2896–2910
24. Grant, P. A., Eberharter, A., John, S., Cook, R. G., Turner, B. M., and
Workman, J. L. (1999) Expanded lysine acetylation specificity of Gcn5 in
native complexes. J. Biol. Chem. 274, 5895–5900
25. Brand, M., Yamamoto, K., Staub, A., and Tora, L. (1999) Identification of
TATA-binding protein-free TAFII-containing complex subunits suggests
a role in nucleosome acetylation and signal transduction. J. Biol. Chem.
274, 18285–18289
26. Guelman, S., Suganuma, T., Florens, L., Swanson, S. K., Kiesecker, C. L.,
Kusch, T., Anderson, S., Yates, J. R., 3rd,Washburn, M. P., Abmayr, S. M.,
andWorkman, J. L. (2006) Host cell factor and an uncharacterized SANT
domain protein are stable components of ATAC, a novel dAda2A/dGcn5-
ATAC and SAGA Subunits Stimulate GCN5 Activity
29008 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 290•NUMBER 48•NOVEMBER 27, 2015
 at U
niversity of Bristol Library Services on M
arch 16, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
containing histone acetyltransferase complex in Drosophila. Mol. Cell.
Biol. 26, 871–882
27. Nagy, Z., Riss, A., Fujiyama, S., Krebs, A., Orpinell, M., Jansen, P., Cohen,
A., Stunnenberg, H. G., Kato, S., and Tora, L. (2010) Themetazoan ATAC
and SAGAcoactivatorHAT complexes regulate different sets of inducible
target genes. Cell. Mol. Life Sci. 67, 611–628
28. Kusch, T., Guelman, S., Abmayr, S. M., and Workman, J. L. (2003) Two
Drosophila Ada2 homologues function in different multiprotein com-
plexes.Mol. Cell. Biol. 23, 3305–3319
29. Muratoglu, S., Georgieva, S., Pápai, G., Scheer, E., Enünlü, I., Komonyi, O.,
Cserpán, I., Lebedeva, L., Nabirochkina, E., Udvardy, A., Tora, L., and
Boros, I. (2003) Two different Drosophila ADA2 homologues are present
in distinct GCN5 histone acetyltransferase-containing complexes. Mol.
Cell. Biol. 23, 306–321
30. Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H., and Nakatani,
Y. (1996) The transcriptional coactivators p300 and CBP are histone
acetyltransferases. Cell 87, 953–959
31. Trievel, R. C., Li, F. Y., and Marmorstein, R. (2000) Application of a fluo-
rescent histone acetyltransferase assay to probe the substrate specificity of
the human p300/CBP-associated factor. Anal. Biochem. 287, 319–328
32. Krebs, A. R., Demmers, J., Karmodiya, K., Chang, N. C., Chang, A. C., and
Tora, L. (2010) ATAC and Mediator coactivators form a stable complex
and regulate a set of non-coding RNA genes. EMBO Rep. 11, 541–547
33. Bonnet, J., Wang, C. Y., Baptista, T., Vincent, S. D., Hsiao, W. C., Stierle,
M., Kao, C. F., Tora, L., and Devys, D. (2014) The SAGA coactivator
complex acts on the whole transcribed genome and is required for RNA
polymerase II transcription. Gene Dev. 28, 1999–2012
34. Feller, C., Forné, I., Imhof, A., and Becker, P. B. (2015) Global and specific
responses of the histone acetylome to systematic perturbation. Mol. Cell
57, 559–571
35. Guelman, S., Kozuka, K., Mao, Y., Pham, V., Solloway,M. J.,Wang, J.,Wu,
J., Lill, J. R., and Zha, J. (2009) The double-histone-acetyltransferase com-
plex ATAC is essential for mammalian development. Mol. Cell. Biol. 29,
1176–1188
36. Wang, Y. L., Faiola, F., Xu, M., Pan, S., and Martinez, E. (2008) Human
ATAC is a GCN5/PCAF-containing acetylase complex with a novel NC2-
like histone fold module that interacts with the TATA-binding protein.
J. Biol. Chem. 283, 33808–33815
37. Ciurciu, A., Komonyi, O., Pankotai, T., and Boros, I. M. (2006) The Dro-
sophila histone acetyltransferase Gcn5 and transcriptional adaptor Ada2a
are involved in nucleosomal histone H4 acetylation. Mol. Cell. Biol. 26,
9413–9423
38. Pankotai, T., Komonyi, O., Bodai, L., Ujfaludi, Z., Muratoglu, S., Ciurciu,
A., Tora, L., Szabad, J., and Boros, I. (2005) The homologous Drosophila
transcriptional adaptors ADA2a andADA2b are both required for normal
development but have different functions.Mol. Cell. Biol. 25, 8215–8227
39. Suganuma, T., Gutiérrez, J. L., Li, B., Florens, L., Swanson, S. K., Wash-
burn, M. P., Abmayr, S. M., and Workman, J. L. (2008) ATAC is a double
histone acetyltransferase complex that stimulates nucleosome sliding.
Nat. Struct. Mol. Biol. 15, 364–372
40. Jin, Q., Yu, L. R., Wang, L., Zhang, Z., Kasper, L. H., Lee, J. E., Wang, C.,
Brindle, P. K., Dent, S. Y., andGe, K. (2011)Distinct roles of GCN5/PCAF-
mediated H3K9ac and CBP/p300-mediated H3K18/27ac in nuclear re-
ceptor transactivation. EMBO J. 30, 249–262
41. Demény, M. A., Soutoglou, E., Nagy, Z., Scheer, E., Jànoshàzi, A., Richar-
dot, M., Argentini, M., Kessler, P., and Tora, L. (2007) Identification of a
small TAF complex and its role in the assembly of TAF-containing com-
plexes. PLoS ONE 2, e316
42. Berger, I., Fitzgerald, D. J., and Richmond, T. J. (2004) Baculovirus expres-
sion system for heterologousmultiprotein complexes.Nat. Biotechnol. 22,
1583–1587
43. Li, M. Z., and Elledge, S. J. (2007) Harnessing homologous recombination
in vitro to generate recombinant DNA via SLIC.Nat.Methods 4, 251–256
44. Trowitzsch, S., Bieniossek, C., Nie, Y., Garzoni, F., and Berger, I. (2010)
New baculovirus expression tools for recombinant protein complex pro-
duction. J. Struct. Biol. 172, 45–54
45. Leurent, C., Sanders, S. L., Demény, M. A., Garbett, K. A., Ruhlmann, C.,
Weil, P. A., Tora, L., and Schultz, P. (2004) Mapping key functional sites
within yeast TFIID. EMBO J. 23, 719–727
46. Karmodiya, K., Krebs, A. R., Oulad-Abdelghani,M., Kimura, H., and Tora,
L. (2012) H3K9 and H3K14 acetylation co-occur at many gene regulatory
elements, while H3K14ac marks a subset of inactive inducible promoters
in mouse embryonic stem cells. BMC Genomics 13, 424
47. Schnitzler, G. R. (2001) Isolation of histones and nucleosome cores from
mammalian cells. Curr. Protoc. Mol. Biol. Chapter 21, Unit 21.5
48. Tropberger, P., Pott, S., Keller, C., Kamieniarz-Gdula, K., Caron,M., Rich-
ter, F., Li, G.,Mittler, G., Liu, E. T., Bühler,M.,Margueron, R., and Schnei-
der, R. (2013) Regulation of transcription through acetylation of H3K122
on the lateral surface of the histone octamer. Cell 152, 859–872
49. Bieniossek, C., Imasaki, T., Takagi, Y., and Berger, I. (2012) MultiBac:
expanding the research toolbox for multiprotein complexes. Trends
Biochem. Sci. 37, 49–57
50. Nguyen-Huynh, N. T., Sharov, G., Potel, C., Fichter, P., Trowitzsch, S.,
Berger, I., Lamour, V., Schultz, P., Potier, N., and Leize-Wagner, E. (2015)
Chemical cross-linking and mass spectrometry to determine the subunit
interaction network in a recombinant human SAGA HAT subcomplex.
Protein Sci. 24, 1232–1246
51. Eberharter, A., John, S., Grant, P. A., Utley, R. T., and Workman, J. L.
(1998) Identification and analysis of yeast nucleosomal histone acetyl-
transferase complexes (in process citation)Methods 15, 315–321
52. Boyer, L. A., Langer, M. R., Crowley, K. A., Tan, S., Denu, J. M., and
Peterson, C. L. (2002) Essential role for the SANT domain in the function-
ing of multiple chromatin remodeling enzymes.Mol. Cell 10, 935–942
53. Sterner, D. E., Wang, X., Bloom, M. H., Simon, G. M., and Berger, S. L.
(2002) The SANT domain of Ada2 is required for normal acetylation of
histones by the yeast SAGA complex. J. Biol. Chem. 277, 8178–8186
54. Köhler, A., Zimmerman, E., Schneider, M., Hurt, E., and Zheng, N. (2010)
Structural basis for assembly and activation of the heterotetrameric SAGA
histone H2B deubiquitinase module. Cell 141, 606–617
55. Samara, N. L., Datta, A. B., Berndsen, C. E., Zhang, X., Yao, T., Cohen,
R. E., and Wolberger, C. (2010) Structural insights into the assembly and
function of the SAGA deubiquitinating module. Science 328, 1025–1029
56. Lang, G., Bonnet, J., Umlauf, D., Karmodiya, K., Koffler, J., Stierle, M.,
Devys, D., and Tora, L. (2011) The tightly controlled deubiquitination
activity of the human SAGA complex differentially modifies distinct gene
regulatory elements.Mol. Cell. Biol. 31, 3734–3744
57. Vermeulen, M., Eberl, H. C., Matarese, F., Marks, H., Denissov, S., Butter,
F., Lee, K. K., Olsen, J. V., Hyman,A.A., Stunnenberg,H.G., andMann,M.
(2010) Quantitative interaction proteomics and genome-wide profiling of
epigenetic histone marks and their readers. Cell 142, 967–980
58. Lu, R., and Wang, G. G. (2013) Tudor: a versatile family of histone meth-
ylation “readers.” Trends Biochem. Sci. 38, 546–555
59. Bian, C., Xu, C., Ruan, J., Lee, K. K., Burke, T. L., Tempel, W., Barsyte, D.,
Li, J., Wu, M., Zhou, B. O., Fleharty, B. E., Paulson, A., Allali-Hassani, A.,
Zhou, J. Q., Mer, G., Grant, P. A., Workman, J. L., Zang, J., and Min, J.
(2011) Sgf29 binds histone H3K4me2/3 and is required for SAGA com-
plex recruitment and histone H3 acetylation. EMBO J. 30, 2829–2842
ATAC and SAGA Subunits Stimulate GCN5 Activity
NOVEMBER 27, 2015•VOLUME 290•NUMBER 48 JOURNAL OF BIOLOGICAL CHEMISTRY 29009
 at U
niversity of Bristol Library Services on M
arch 16, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Tora
Anne Riss, Elisabeth Scheer, Mathilde Joint, Simon Trowitzsch, Imre Berger and László
(SAGA) Coactivator Complexes Enhance the Acetyltransferase Activity of GCN5
Subunits of ADA-two-A-containing (ATAC) or Spt-Ada-Gcn5-acetyltrasferase
doi: 10.1074/jbc.M115.668533 originally published online October 14, 2015
2015, 290:28997-29009.J. Biol. Chem. 
  
 10.1074/jbc.M115.668533Access the most updated version of this article at doi: 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  
 to choose from all of JBC's e-mail alertsClick here
Supplemental material:
  
 http://www.jbc.org/content/suppl/2015/10/14/M115.668533.DC1.html
  
 http://www.jbc.org/content/290/48/28997.full.html#ref-list-1
This article cites 58 references, 30 of which can be accessed free at  at U
niversity of Bristol Library Services on M
arch 16, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
